Reuters logo
Strides Arcolab shares sink on dividend worries
February 28, 2013 / 4:23 AM / 5 years ago

Strides Arcolab shares sink on dividend worries

MUMBAI (Reuters) - Shares in drugmaker Strides Arcolab STAR.NS plummeted about 10 percent on Thursday, wiping out early gains following its sale of a unit to Mylan (MYL.O) for $1.6 billion, as investors were unhappy with Strides’ dividend payout, traders said.

The shares had initially gained as much as 13.2 percent.

The company declared a 20 percent dividend, or 2 rupees per share, for 2012.

Strides’ injectables unit Agila Specialties generated $700 million in sales and an operating profit of $86 million in year 2012, Strides said.

The Bangalore-based drugmaker said it planned to spend $700 million to $800 million at pretax level on shareholders.

Valued at $1.1 billion, shares in Strides Arcolab were down 8.5 percent at 902.95 rupees by 9:51 a.m. when the Mumbai market was up 0.55 percent.

Reporting by Kaustubh Kulkarni; Editing by Gopakumar Warrier

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below